"Current pathology techniques" symposium review: Advances and issues in neuropathology

Toxicologic Pathology

Volumn 36, Issue 6, 2008, Pages 871-889

  Bolon, Brad ^a   Anthony, Douglas C ^b   Butt, Mark ^c   Dorman, David ^d   Green, Michael V ^e   Little, Peter B ^f   Valentine, William M ^g   Weinstock, Daniel ^h   Yan, James ⁱ   Sills, Robert C ^j  

^a GEMpath Inc   (United States)

^b University of Missouri   (United States)

^c Tox Path Specialists   (United States)

^d NORTH CAROLINA STATE UNIVERSITY   (United States)

^e Trident Imaging Inc   (United States)

^f CHARLES RIVER LABORATORIES   (United States)

^g VANDERBILT UNIVERSITY   (United States)

^h SANOFI   (France)

ⁱ Hospira Inc   (United States)

^j NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

more..

Author keywords

Neuropathology; Neurotoxicity; Review

Indexed keywords

DEGENERATIVE DISEASE; HISTOPATHOLOGY; HUMAN; MEDICAL RESEARCH; NEUROBIOLOGY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 54949105766     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623308322313     Document Type: Review

References (99)

1. Abbott, NJ (2004). Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int, 45, 545-52.
2. Aldape, K, DG Ginzinger, and TE Godfrey (2002). Real-time quantitative polymerase chain reaction: A potential tool for genetic analysis in neuropathology. Brain Pathol, 12, 54-66.
3. Anonymous (1991). Poisoning the border: Many American-owned factories in Mexico are fouling the environment, and their workers aren't prospering. US News and World Report, 110, 32-36.
4. Anthony, DC, TJ Montine, WM Valentine, and DG Graham (2002). Toxic responses of the nervous system. In CD Klaassen (Ed.), Casarett & Doull's Toxicology: The Basic Science of Poisons, 6th ed (pp. 535-64). New York: McGraw Hill.
5. Aschner, M, U Sonnewald, and KH Tan (2002). Astrocyte modulation of neurotoxic injury. Brain Pathol, 12, 475-81.
6. Bagnell, R, C Langaman, V Madden, and K Suzuki (1995). Ultrastructural methods for neurotoxicology and neuropathology. In LW Chang and WJ Slikker (Eds.), Neurotoxicology: Approaches and Methods (pp. 81-98). San Diego: Academic Press.
7. Bearer, CF (2001). Developmental neurotoxicity: Illustration of principles. Pediatr Clin North Am, 48, 1199-213.
8. Benveniste, H, K Kim, L Zhang, and GA Johnson (2000). Magnetic resonance microscopy of the C57BL mouse brain. NeuroImage, 11, 601-11.
9. Böhm, C, D Newrzella, and O Sorgenfrei (2005). Laser microdissection in CNS research. Drug Disc Today, 10, 1167-74.
10. Bolon, B (2000). Comparative and correlative neuroanatomy for the toxicologic pathologist. Toxicol Pathol, 28, 6-27.
11. Bolon, B, R Garman, K Jensen, G Krinke, and B Stuart (2006). A 'best practices' approach to neuropathologic assessment in developmental neurotoxicity testing - for today. Toxicol Pathol, 34, 296-313.
12. Boyes, WK (2001). Neurotoxicology and behavior. In E Bingham, B Cohrssen and CH Powell (Eds.), Patty's Toxicology, 5th ed (pp. 55-121). Hoboken, NJ: John Wiley & Sons.
13. Broxup, B (1991). Neuropathology as a screen for neurotoxicity assessment. J Am Coll Toxicol, 10, 689-95.
14. Buelke-Sam, J, and CA Kimmel (1979). Development and standardization of screening methods for behavioral teratology. Teratology, 20, 17-30.
15. Butler, H, and BHJ Juurlink (1987). An Atlas for Staging Mammalian and Chick Embryos. Boca Raton, FL: CRC Press.
16. Calabresi, P, D Centonze, and G Bernardi (2000). Cellular factors controlling neuronal vulnerability in the brain: A lesson from the striatum. Neurology, 55, 1249-55.
17. Cassella, J, J Hay, and S Lawson (1997). The Rat Nervous System: An Introduction to Preparatory Techniques. In. New York: John Wiley & Sons.
18. Chatziioannou, A (2002). Molecular imaging of small animals with dedicated PET tomographs. Eur J Nucl Med, 29, 98-114.
19. Chernoff, N, RJ Kavlock, PE Beyer, and D Miller (1987). The potential relationship of maternal toxicity, general stress, and fetal outcome. Teratogen Carcinogen Mutagen, 7, 241-53.
20. Claudio, L (1992). An analysis of the U.S. Environmental Protection Agency neurotoxicity testing guidelines. Regul Toxicol Pharmacol, 16, 202-12.
21. Colin-Barenque, L, MR Avila-Costa, T Fortoul, C Rugerio-Vargas, JP Machado-Salas, J Espinosa-Villanueva, and S Rivas-Arancibia (1999). Morphologic alteration of the olfactory bulb after acute ozone exposure in rats. Neurosci Lett, 274, 1-4.
22. Connelly, JM, and MG Malkin (2007). Environmental risk factors for brain tumors. Curr Neurol Neurosci Rep, 7, 208-14.
23. Crews, FT, CJ Braun, B Hoplight, RC Switzer, 3rd, and DJ Knapp (2000). Binge ethanol consumption causes differential brain damage in young adolescent rats compared with adult rats. Alcohol Clin Exp Res, 24, 1712-23.
24. Dheen, ST, C Kaur, and EA Ling (2007). Microglial activation and its implications in the brain diseases. Curr Med Chem, 14, 1189-97.
25. Does, MD, and RE Snyder (1996). Multiexponential T2 relaxation in degenerating peripheral nerve. Magn Resonance Med, 35, 207-13.
26. Dorman, DC (2000). An integrative approach to neurotoxicology. Toxicol Pathol, 28, 37-42.
27. Dyck, PJ and PK Thomas (Eds.) (2005). Peripheral Neuropathy. Philadelphia: Elsevier Saunders.
28. Eisenbrandt, DL, JL Mattsson, RR Albee, PJ Spencer, and KA Johnson (1990). Spontaneous lesions in subchronic neurotoxicity testing of rats. Toxicol Pathol, 18, 154-64.
29. Eng, LF, RS Ghirnikar, and YL Lee (2000). Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res, 25, 1439-51.
30. Environmental Defense Fund (1997). Toxic Ignorance: The Continuing Absence of Basic Health Testing for Top-Selling Chemicals in the United States. Washington, DC: Environmental Defense Fund.
31. Fix, AS, and RH Garman (2000). Practical aspects of neuropathology: A technical guide for working with the nervous system. Toxicol Pathol, 28, 122-31.
32. Fix, AS, JF Ross, SR Stitzel, and RC Switzer (1996). Integrated evaluation of central nervous system lesions: Stains for neurons, astrocytes and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex. Toxicol Pathol, 24, 291-304.
33. Fujita, M, M Imaizumi, C D'Sa, SS Zoghbi, MS Crescenzo, J Hong, JL Musachio, AD Gee, J Seidel, MV Green, VW Pike, RS Duman, and RB Innis (2007). In vivo and in vitro measurement of brain phosphodiesterase 4 in rats after antidepressant administration. Synapse, 61, 78-86.
34. Fuller, CE, and A Perry (2002). Fluorescence in situ hybridization (FISH) in diagnostic and investigative neuropathology. Brain Pathol, 12, 67-86.
35. Garman, RH (1990). Artifacts in routinely immersion fixed nervous tissue. Toxicol Pathol, 18, 149-53.
36. Garman, RH (2003). Evaluation of large-sized brains for neurotoxic endpoints. Toxicol Pathol, 31, 32-43.
37. Garman, RH, AS Fix, BS Jortner, KF Jensen, JF Hardisty, L Claudio, and S Ferenc (2001). Methods to identify and characterize developmental neurotoxicity for human health risk assessement. II: Neuropathology. Environ Health Perspec, 109 (Suppl. 1). 93-100.
38. Gobba, F (2003). Occupational exposure to chemicals and sensory organs: a neglected research field. Neurotoxicology, 24, 675-91.
39. Godfrey, KM, and DJ Barker (2001). Fetal programming and adult health. Public Health Nutr, 4, 611-24.
40. Goldman, LR (1998). Linking research and policy to ensure children's environmental health. Environ Health Perspect, 106 (Suppl. 3). 857-62.
41. Gottfried, MR, DG Graham, M Morgan, HW Casey, and JS Bus (1985). The morphology of carbon disulfide neurotoxicity. Neurotoxicology, 6, 89-96.
42. Graham, DG, V Amarnath, WM Valentine, SJ Pyle, and DC Anthony (1995). Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol, 25, 91-112.
43. Green, MV, J Seidel, JJ Vaquero, E Jagoda, I Lee, and WC Eckelman (2001). High resolution PET, SPECT and projection Imaging in small animals. Comp Med Imag Graphics, 25, 79-86.
44. Gujar, SK, S Maheshwari, I Bjorkman-Burtscher, and PC Sundgren (2005). Magnetic resonance spectroscopy. J Neuroophthamol, 25, 217-26.
45. Heckl, S, R Pipkorn, T Nagele, U Vogel, W Kuker, and K Voight (2004). Molecular imaging: Bridging the gap between neuroradiology and neurohistology. Histol Histopathol, 19, 651-68.
46. Herr, DW, JE Graff, VC Moser, KM Crofton, PB Little, DL Morgan, and RC Sills (2007). Inhalational exposure to carbonyl sulfide produces altered brainstem auditory and somatosensory-evoked potentials in Fischer 344N rats. Toxicol Sci, 95, 118-35.
47. Hesselbarth, D, C Franke, R Hata, G Brinker, and M Berlage-Hoehn (1998). High resolution MRI and MRS: A feasibility study for the investigation of focal cerebral ischemia in mice. NMR Biomed, 11, 423-29.
48. Jortner, BS (2006). The return of the dark neuron. A histological artifact complicating contemporary neurotoxicologic evaluation. Neurotoxicology, 27, 628-34.
49. Kaufmann, W (2003). Current status of developmental neurotoxicity: An industry perspective. Toxicol Lett, 140-141, 161-69.
50. King, R (1999). Atlas of Peripheral Nerve Pathology. London: Arnold.
51. Kornguth, S, M Anderson, JL Markley, and A Shedlovsky (1994). Near-microscopic magnetic resonance imaging of the brains of phenylalanine hydroxylase-deficient mice, normal littermates, and of normal BALB/c mice at 9.4 Tesla. NeuroImage, 1, 220-29.
52. Kostrzewa, RM, and R Brus (1998). Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor. Amino Acids, 14, 175-79.
53. Krinke, GJ, W Classen, M Rauch, and E Weber (1997). Optimal conduct of the neuropathology evaluation of organophosphorus induced delayed neuropathy in hens. Exp Toxicol Pathol, 49, 451-58.
54. Law, M, M Hamburger, G Johnson, M Inglese, A Londono, J Golfinos, D Zagzag, and EA Knopp (2004). Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging. Technol Cancer Res Treat, 3, 557-65.
55. Maeda, K, R Hata, and KA Hossmann (1999). Regional metabolic disturbances and cerebrovascular anatomy after permanent middle cerebral artery occlusion in C57BL/6 and SV129 mice. Neurobiol Disease, 6, 101-8.
56. Marcus, KJ, LG Astrakas, D Zurakowski, MK Zarifi, D Mintzopoulos, TY Poussaint, DC Anthony, U DeGirolami, PM Black, NJ Tarbell, and AA Tzika (2007). Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Internat J Oncol, 30, 651-57.
57. Maronpot, RR, RC Sills, and A Johnson (2004). Applications of magnetic resonance microscopy. Toxicol Pathol, 32, 42-48.
58. Mattsson, JL, DL Eisenbrandt, and RR Albee (1990). Screening for neurotoxicity: Complementarity of functional and morphologic techniques. Toxicol Pathol, 18, 115-27.
59. Maurissen, JP, and BR Marable (2005). Neurotoxicity test validation, positive controls and proficiency: Are chemicals necessary? Neurotoxicol Teratol, 27, 545-51.
60. Mischel, PS, TF Cloughesy, and SF Nelson (2004). DNA-microarray analysis of brain cancer: Molecular classification for therapy. Nat Rev Neurosci, 5, 782-92.
61. Morgan, DL, PB Little, DW Herr, VC Moser, B Collins, R Herbert, GA Johnson, RR Maronpot, GJ Harry, and RC Sills (2004). Neurotoxicity of carbonyl sulfide in F344 rats following inhalation exposure for up to 12 weeks. Toxicol Appl Pharmacol, 200, 131-45.
62. Moser, VC (1990). Approaches for assessing the validity of a functional observational battery. Neurotoxicol Teratol, 12, 483-88.
63. Moser, VC (2000). The functional observational battery in adult and developing rats. Neurotoxicology, 21, 989-96.
64. Moser, VC, PM Phillips, DL Morgan, and RC Sills (1998). Carbon disulfide neurotoxicity in rats: VII. Behavioral evaluations using a functional observational battery. Neurotoxicology, 19, 147-57.
65. O'Callaghan, J, and K Sriram (2005). Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin Drug Safety, 4, 433-42.
66. Organisation for Economic Cooperation and Development (OECD) (1997).. Test Guideline 424: Neurotoxicity Study in Rodents.
67. Organisation for Economic Cooperation and Development (OECD) (2007).. OECD Guideline for the Testing of Chemicals: Guideline 426, Developmental Neurotoxicity Study.
68. Pekny, M, and M Pekna (2004). Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol, 204, 428-37.
69. Purpura, DP (1974). Dendritic spine 'dysgenesis' and mental retardation. Science, 186, 1126-28.
70. Redzic, ZB, and MB Segal (2004). The structure of the choroid plexus and the physiology of the choroid plexus epithelium. Adv Drug Deliv Rev, 56, 1695-716.
71. Reuhl, KR (1991). Delayed expression of neurotoxicity: The problem of silent damage. Neurotoxicology, 12, 341-46.
72. Rice, D, and SJ Barone (2000). Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect, 108 (Suppl. 3). 511-33.
73. Rodier, PM (1980). Chronology of neuron development: Animal studies and their clinical implications. Dev Med Child Neurol, 22, 525-45.
74. Romero, E, O Cuisenaire, JF Denef, J Delbeke, B Macq, and C Veraart (2000). Automatic morphometry of nerve histological sections. J Neurosci Meth, 97, 111-22.
75. Saver, JL (2006). Time is brain - quantified. Stroke, 37, 263-66.
76. Schaeppi, U, and G Krinke (1985). Differential vulnerability of 3 rapidly conducting somatosensory pathways in the dog with vitamin B6 neuropathy. Agents Actions, 16, 567-79.
77. Schmued, LC, and KJ Hopkins (2000a). Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol Pathol, 28, 91-99.
78. Schmued, LC, and KJ Hopkins (2000b). Fluoro-Jade B: a high affinity tracer for the localization of neuronal degeneration. Brain Res, 874, 123-30.
79. Schmued, LC, CC Stowers, AC Scallet, and L Xu (2005). Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res, 1035, 24-31.
80. Seidel, J, JJ Vaquero, and MV Green (2003). Resolution uniformity and sensitivity of the NIH ATLAS small animal PET scanner: comparison to simulated LSO scanners without depth-of-interaction capability. IEEE Trans Nucl Sci, 50, 1347-50.
81. Shimoji, K, L Ravasi, K Schmidt, M Luisa-Soto Montenegro, T Esaki, J Seidel, E Jagoda, L Sokoloff, M Green, and W Eckelman (2004). Measurement of cerebral glucose metabolic rates in the anesthetized rat by dynamic scanning with 18-F FDG, the ATLAS small animal PET scanner, and arterial blood sampling. J Nucl Med, 45, 665-72.
82. Sills, RC, GJ Harry, DL Morgan, WM Valentine, and DG Graham (1998). Carbon disulfide neurotoxicity in rats: V. Morphology of axonal swelling in the muscular branch of the posterior tibial nerve and spinal cord. Neurotoxicology, 19, 117-27.
83. Sills, RC, GJ Harry, WM Valentine, and DL Morgan (2005). Interdisciplinary neurotoxicity inhalation studies: Carbon disulfide and carbonyl sulfide research in F344 rats. Toxicol Appl Pharmacol, 207, S245 - S250.
84. Sills, RC, DL Morgan, DW Herr, PB Little, TV Ton, NE Love, RR Maronpot, and GA Johnson (2004). Contribution of magnetic resonance microscopy in the 12-week neurotoxicity evaluation of carbonyl sulfide in Fischer 344 rats. Toxicol Pathol, 32, 501-10.
85. Sokoloff, L (1981). Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose. J Cereb Blood Flow Metab, 36, 7-36.
86. Sokoloff, L, M Reivicii, C Kennedy, MH Des Rosiers, CS Patlak, KD Pettigre, O Sakurada, and M Shinohara (1977). The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem, 28, 897-916.
87. Solleveld, HA, and GA Boorman (1990). Brain. In GA Boorman, SL Eustis, MR Elwell, CAJ Montgomery and WF MacKenzie (Eds.), Pathology of the Fischer Rat (pp. 155-77). San Diego: Academic Press.
88. Suehiro, M, U Scheffel, RF Dannals, HT Ravert, GA Ricaurte, and HN Wagner, Jr (1993). A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z. J Nucl Med, 34, 120-27.
89. Switzer, RCI (1991). Strategies for assessing neurotoxicity. Neurosci Biobehav Rev, 15, 89-93.
90. Switzer, RCI (2000). Application of silver degeneration stains to neurotoxicity testing. Toxicol Pathol, 28, 70-83.
91. Tai, YC, A Chatziioannou, S Siegel, J Young, D Newport, RN Goble, RE Nutt, and SR Cherry (2001). Performance evaluation of the microPET P4: a PET system dedicated to animal imaging. Phys Med Biol, 46, 1845-62.
92. Thomas, DM, DM Francescutti-Verbeem, X Liu, and DM Kuhn (2004). Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment - an oligonucleotide microarray approach. J Neurochem, 88, 380-93.
93. Toyama, H, M Ichise, J Liow, K Modell, D Vines, T Esaki, M Cook, J Seidel, L Sokoloff, MV Green, and R Innis (2004). Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG in small animal PET and 2-14C-DG autoradiography. J Nucl Med, 45, 1398-405.
94. Toyama, H, D Ye, M Ichise, J Liow, L Cai, D Jacobowitz, JL Musachio, J Hong, M Crescenzo, D Tipre, JQ Lu, S Zoghbi, DC Vines, J Seidel, K Katada, MV Green, VW Pike, RM Cohen, and RB Innis (2005). PET imaging of brain with the β-amyloid probe, [C-11]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imaging, 32, 593-600.
95. U.S. Environmental Protection Agency (EPA) (1998a).. Health Effects Test Guidelines: OPPTS 870.6200, Neurotoxicity Screening Battery.
96. U.S. Environmental Protection Agency (EPA) (1998b).. Health Effects Test Guidelines: OPPTS 870.6300, Developmental Neurotoxicity Study.
97. Valentine, HL, MD Does, V Marshall, EG Tonkin, and WM Valentine (2007). Multicomponent T2 analysis of dithiocarbamate-mediated peripheral nerve demyelination. Neurotoxicology, 28, 645-54.
98. Webb, S, CA Munro, R Midha, and GJ Stanisz (2003). Is multicomponent T2 a good measure of myelin content in peripheral nerve? Magn Resonance Med, 49, 638-45.
99. Ye, X, R Carp, L Schmued, and A Scallet (2001). Fluoro-Jade and silver methods: Application to the neuropathology of scrapie, a transmissible spongiform encephalopathy. Brain Res Brain Res Protoc, 8, 104-12.